WANBURY Financial Statement Analysis
|
||
|
The Revenues of WANBURY have increased by 30.23% YoY .
The Earnings Per Share (EPS) of WANBURY has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
WANBURY Last 5 Annual Financial Results
[BOM: 524212|NSE : WANBURY]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹511 Cr | ₹393 Cr | ₹367 Cr | ₹391 Cr | ₹371 Cr |
| Expenses | ₹479 Cr | ₹377 Cr | ₹389 Cr | ₹378 Cr | ₹439 Cr |
| Operating Profit (Excl OI) | ₹32 Cr | ₹16 Cr | ₹-22 Cr | ₹13 Cr | ₹-68 Cr |
| Other Income | ₹5.09 Cr | ₹4.75 Cr | ₹46 Cr | ₹12 Cr | ₹77 Cr |
| Interest | ₹21 Cr | ₹23 Cr | ₹33 Cr | ₹40 Cr | ₹31 Cr |
| Depreciation | ₹11 Cr | ₹9.75 Cr | ₹9.68 Cr | ₹9.97 Cr | ₹10 Cr |
| Profit Before Tax | ₹81 Cr | ₹-12 Cr | ₹65 Cr | ₹-25 Cr | ₹-32 Cr |
| Profit After Tax | ₹81 Cr | ₹-13 Cr | ₹64 Cr | ₹-25 Cr | ₹-32 Cr |
| Consolidated Net Profit | ₹81 Cr | ₹-13 Cr | ₹64 Cr | ₹-25 Cr | ₹-32 Cr |
| Earnings Per Share (Rs) | ₹-3.18 | ₹24.94 | ₹-5.04 | ₹25.79 | ₹-10.48 |
| PAT Margin (%) | -2.04 | 15.83 | -3.20 | 17.38 | -5.97 |
| ROE(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE(%) | 29.82 | 428.78 | 87.61 | 444.45 | 50.26 |
| Total Debt/Equity(x) | -1.86 | -2.72 | -1.02 | -1.14 | -1.11 |
Key Financials |
||
| Market Cap | : | ₹ 513.9 Cr |
| Revenue (TTM) | : | ₹ 569.2 Cr |
| Net Profit(TTM) | : | ₹ 23.3 Cr |
| EPS (TTM) | : | ₹ 7.1 |
| P/E (TTM) | : | 22.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| WANBURY | 4.4% | 17.3% | 308.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
| CIPLA | 4.5% | -3.1% | 52.8% |
| DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
| ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
| DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
| MANKIND PHARMA | 2.7% | 12.4% | NA |
| TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
| LUPIN | 3.1% | -1.1% | 127.4% |
WANBURY Revenues
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | 30.23 % |
| 5 Yr CAGR | 8.34 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹511 Cr | 30.23 | |
| Mar2022 | ₹393 Cr | 6.82 | |
| Mar2021 | ₹367 Cr | -6.11 | |
| Mar2020 | ₹391 Cr | 5.46 | |
| Mar2019 | ₹371 Cr | - | |
WANBURY Operating Profit
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | 102.52 % |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹32 Cr | 102.52 | |
| Mar2022 | ₹16 Cr | Positive | |
| Mar2021 | ₹-22 Cr | Negative | |
| Mar2020 | ₹13 Cr | Positive | |
| Mar2019 | ₹-68 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 55.64 % |
| 5 Yr CAGR | Positive |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 6.21% | 55.64 | |
| Mar2022 | 3.99% | Positive | |
| Mar2021 | -5.88% | Negative | |
| Mar2020 | 3.42% | Positive | |
| Mar2019 | -18.3% | - | |
WANBURY Profit After Tax
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹81 Cr | Positive | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹64 Cr | Positive | |
| Mar2020 | ₹-25 Cr | Negative | |
| Mar2019 | ₹-32 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | -2.04 % | Negative | |
| Mar2022 | 15.83 % | Positive | |
| Mar2021 | -3.2 % | Negative | |
| Mar2020 | 17.38 % | Positive | |
| Mar2019 | -5.97 % | - | |
WANBURY Earnings Per Share (EPS)
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹-3.18 | Negative | |
| Mar2022 | ₹25 | Positive | |
| Mar2021 | ₹-5.04 | Negative | |
| Mar2020 | ₹26 | Positive | |
| Mar2019 | ₹-10 | - | |
WANBURY Return on Capital Employed (ROCE)
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | -93.05 % |
| 5 Yr CAGR | -12.24 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 29.82% | -93.05 | |
| Mar2022 | 428.78% | 389.42 | |
| Mar2021 | 87.61% | -80.29 | |
| Mar2020 | 444.45% | 784.30 | |
| Mar2019 | 50.26% | - | |
WANBURY Share Price vs Sensex
| Current Share Price | : | ₹157.2 |
| Current MarketCap | : | ₹ 513.9 Cr |
| Updated EOD on | : | Apr 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 4.4% |
17.3% |
308.9% |
| SENSEX | 0.9% |
1.5% |
23.6% |
WANBURY related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about WANBURY Financials
How the annual revenues of WANBURY have changed ?
The Revenues of WANBURY have increased by 30.23% YoY .
How the Earnings per Share (EPS) of WANBURY have changed?
The Earnings Per Share (EPS) of WANBURY has decreased by Negative YoY .
Check out Intrinsic Value of Peers of WANBURY
Compare Stock Analytics of Peers of WANBURY
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
